Genix Pharmaceuticals Corporation GENX.V Stock
Genix Pharmaceuticals Corporation Price Chart
Genix Pharmaceuticals Corporation GENX.V Financial and Trading Overview
| Genix Pharmaceuticals Corporation stock price | 0.07 CAD |
| Previous Close | 0.06 CAD |
| Open | 0.06 CAD |
| Bid | 0.05 CAD x N/A |
| Ask | 0.06 CAD x N/A |
| Day's Range | 0.06 - 0.06 CAD |
| 52 Week Range | 0.04 - 0.14 CAD |
| Volume | 3K CAD |
| Avg. Volume | 6.41K CAD |
| Market Cap | 3.26M CAD |
| Beta (5Y Monthly) | -0.882154 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GENX.V Valuation Measures
| Enterprise Value | 3.55M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2058.9917 |
| Price/Book (mrq) | 1.1 |
| Enterprise Value/Revenue | 2242.46 |
| Enterprise Value/EBITDA | -10.002 |
Trading Information
Genix Pharmaceuticals Corporation Stock Price History
| Beta (5Y Monthly) | -0.882154 |
| 52-Week Change | -53.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.14 CAD |
| 52 Week Low | 0.04 CAD |
| 50-Day Moving Average | 0.05 CAD |
| 200-Day Moving Average | 0.06 CAD |
GENX.V Share Statistics
| Avg. Volume (3 month) | 6.41K CAD |
| Avg. Daily Volume (10-Days) | 24.6K CAD |
| Shares Outstanding | 59.22M |
| Float | 33.27M |
| Short Ratio | 0 |
| % Held by Insiders | 44.66% |
| % Held by Institutions | 0% |
| Shares Short | 1 |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -56341.15% |
| Gross Margin | 52.14% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -12.81% |
| Return on Equity (ttm) | -28.33% |
Income Statement
| Revenue (ttm) | 1.58K CAD |
| Revenue Per Share (ttm) | 0 CAD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -354683 CAD |
| Net Income Avi to Common (ttm) | -962539 CAD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 41.29K CAD |
| Total Cash Per Share (mrq) | 0.001 CAD |
| Total Debt (mrq) | 331.53K CAD |
| Total Debt/Equity (mrq) | 11.16 CAD |
| Current Ratio (mrq) | 0.239 |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -240497 CAD |
| Levered Free Cash Flow (ttm) | 92.8K CAD |
Profile of Genix Pharmaceuticals Corporation
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 1055 West Hastings Street |
| ZIP | V6E 2E9 |
| Phone | 604 609 6198 |
| Website | https://www.genixpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that manages blood sugar. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Q&A For Genix Pharmaceuticals Corporation Stock
What is a current GENX.V stock price?
Genix Pharmaceuticals Corporation GENX.V stock price today per share is 0.07 CAD.
How to purchase Genix Pharmaceuticals Corporation stock?
You can buy GENX.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genix Pharmaceuticals Corporation?
The stock symbol or ticker of Genix Pharmaceuticals Corporation is GENX.V.
Which industry does the Genix Pharmaceuticals Corporation company belong to?
The Genix Pharmaceuticals Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Genix Pharmaceuticals Corporation have in circulation?
The max supply of Genix Pharmaceuticals Corporation shares is 59.22M.
What is Genix Pharmaceuticals Corporation Price to Earnings Ratio (PE Ratio)?
Genix Pharmaceuticals Corporation PE Ratio is now.
What was Genix Pharmaceuticals Corporation earnings per share over the trailing 12 months (TTM)?
Genix Pharmaceuticals Corporation EPS is -0.07 CAD over the trailing 12 months.
Which sector does the Genix Pharmaceuticals Corporation company belong to?
The Genix Pharmaceuticals Corporation sector is Healthcare.